(Press-News.org) Philadelphia, PA, April 2, 2015 - With each new amyloid-targeting treatment for Alzheimer's disease that has been developed, there has been a corresponding concern. For example, antibodies targeting amyloid-β peptide (Aβ) produce inflammation in the brain in some patients. Gamma secretase inhibitors tend to produce adverse effects by interacting with Notch, an important pathway for cellular signaling.
Beta secretase 1 (BACE1) inhibitors are a new and promising target for Alzheimer's disease. Inhibiting BACE1 will limit the production of Aβ which, in turn, should reduce the production of neurotoxic fibrils and plaques.
"Since several BACE1 inhibitors are currently being evaluated in clinical phase 3 trials for the treatment of Alzheimer's disease, the identification of potential side effects will be of great importance to ensure a positive clinical outcome," said Dr. Jochen Herms, a Professor of translational brain research at Ludwig-Maximilians-University Munich.
He and his team have now gathered that data by exploring the impact of long-term BACE1 inhibition on dendritic spine dynamics, synaptic functions, and cognitive performance in adult mice. Their work is published in the current issue of Biological Psychiatry.
They found that pharmacological BACE1 inhibition reduced dendritic spine dynamics, reduced neurotransmission, and impaired cognition. Importantly, however, these disruptive effects were dose dependent.
Dr. Herms explained, "Our study demonstrates that moderate inhibition of BACE1 might be therapeutically efficient without any overt signs of health impairments. On the contrary, we found that strong inhibition of BACE1 in mice causes structural and functional synaptic alterations with deterioration of cognitive performance."
Dr. John Krystal, Editor of Biological Psychiatry, commented, "Alzheimer's disease presents such a terrible burden on individuals, families, and society that if BACE1 inhibitors produce beneficial effects on the course of this disorder, it is well worth the effort to try to understand and circumvent this new risk."
Indeed, the clinical efficacy of BACE1 inhibitors remains unknown until the phase 3 trials currently underway are completed. In the meantime, these findings suggest that careful dosage of BACE1 inhibitors will be necessary to avoid potential adverse effects. The authors urge utmost caution in the dosage of drugs targeting BACE1 in order to achieve a therapeutic window that balances both safety and efficacy.
INFORMATION:
The article is "Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions" by Severin Filser, Saak V. Ovsepian, Mercè Masana, Lidia Blazquez?Llorca, Anders Brandt Elvang, Christiane Volbracht, Marianne B. Müller, Christian K.E. Jung, and Jochen Herms (doi: 10.1016/j.biopsych.2014.10.013). The article appears in Biological Psychiatry, Volume 77, Issue 8 (April 15, 2015), published by Elsevier.
Notes for editors
Full text of the article is available to credentialed journalists upon request; contact Rhiannon Bugno at +1 214 648 0880 or Biol.Psych@utsouthwestern.edu. Journalists wishing to interview the authors may contact Jochen Herms at +49 (0) 89 / 2180-78010 or Jochen.Herms@med.uni-muenchen.de.
The authors' affiliations, and disclosures of financial and conflicts of interests are available in the article. John H. Krystal, M.D., is Chairman of the Department of Psychiatry at the Yale University School of Medicine, Chief of Psychiatry at Yale-New Haven Hospital, and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available here.
About Biological Psychiatry
Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders. The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged. Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 5th out of 135 Psychiatry titles and 14th out of 251 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2013 Impact Factor score for Biological Psychiatry is 9.472.
About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make ground-breaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries.
SEATTLE - As the global population pushes past 7 billion and more people reach old age, the number of deaths from cardiovascular diseases is on the rise. Cardiovascular diseases, the leading cause of premature death in the world, include heart attacks, strokes, and other circulatory diseases.
At the same time, efforts to prevent and treat cardiovascular diseases appear to be working as the rise in deaths is slower than the overall growth of the population.
Globally, the number of deaths due to cardiovascular diseases increased by 41% between 1990 and 2013, climbing ...
Scientists from Nanyang Technological University (NTU Singapore) and Sweden's Karolinska Institutet, one of Europe's largest and most prestigious medical universities, have discovered that an existing chemotherapy drug used to treat leukaemia could prevent and control the growth of colorectal tumours.
Colorectal cancer commonly referred to as colon cancer is one of the three most common cancers worldwide and the most common in Singapore. Almost 95 per cent of colorectal cancers are from malignant tumours.
The research team found that Imatinib, an enzyme blocker widely ...
Reporting under policy instruments to inform on the trends in biodiversity requires information from a range of different elements of biodiversity, from genetically viable populations to the structure of ecosystems. A new research looks into the Essential Biodiversity Variables as an analytic framework to identify ways in which gaps between biodiversity data and policy reporting needs could be bridged. The study was published in the Journal of Applied Ecology.
The Essential Biodiversity Variables (EBVs, Pereira et al. 2013) which were previously developed by ecology experts ...
The findings, which have been published in the American Journal of Clinical Nutrition, are in line with previous studies of eating habits that indicated a link between high consumption of dairy products and a reduced risk of type 2 diabetes.
However, the new study indicates that it is high-fat dairy products specifically that are associated with reduced risk.
"Those who ate the most high-fat dairy products had a 23 per cent lower risk of developing type 2 diabetes than those who ate the least. High meat consumption was linked to an increased risk of type 2 diabetes ...
Researchers at the University of Warwick and UHCW have discovered how body clock genes could affect women's ability to have children.
The study, by medics at Warwick Medical School and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, pinpoints how body clock genes are temporarily switched off in the lining of the womb to allow an embryo to implant. Timing of this event is critical for pregnancy.
The researchers examined endometrial cells from womb linings of healthy women, and also biopsies from women who had sadly suffered from recurrent pregnancy ...
Egg consumption may reduce the risk of type 2 diabetes, according to new research from the University of Eastern Finland. The findings were published in American Journal of Clinical Nutrition.
Type 2 diabetes is becoming increasingly widespread throughout the world. Research has shown that lifestyle habits, such as exercise and nutrition, play a crucial role in the development of the disease. In some studies, high-cholesterol diets have been associated with disturbances in glucose metabolism and risk of type 2 diabetes. In contrast, in some experimental studies, the consumption ...
An illuminating study compares the willingness of stage IV cancer patients, and their caregivers; to pay to extend their lives by one year against that of other end-of-life improvements. The research, led by members of the Lien Centre for Palliative Care (LCPC) and collaborators from the National Cancer Centre Singapore, was recently published in the journal, Palliative Medicine.
Patients with advanced cancer or other life limiting illnesses often have to consider how much money they are willing to spend on high cost treatments that result in only moderate improvements ...
University of Adelaide researchers have shown there are two critical windows during the developmental pathway to adulthood when exposure to junk food is most harmful, particularly for female offspring.
This work leads on from earlier findings which showed that mothers who eat junk food while pregnant are programming their babies to be addicted to a high fat, high sugar diet by the time they are weaned.
Their latest laboratory studies reveal there may be a chance to turn around this junk food addiction in two critical windows--equating to late pregnancy and in adolescence ...
The use of technology in daily life is getting easier all the time as people accumulate knowledge and skills in information and communications technology. However, the most important thing in developing health care services, for example, is to take into account people's day to day lives and their subjective experience of the utility of using services. For example, people's previous bad experience of using a service is reflected for a long time in their use of the service in the future, and thus the dissemination of new service models is a lot slower than might be imagined. ...
DARIEN, IL - A new study suggests that symptoms of depression and insomnia are the strongest predictors of having frequent nightmares.
Results show that 3.9 percent of participants reported having frequent nightmares during the previous 30 days, including 4.8 percent of women and 2.9 percent of men. Frequent nightmares were reported by 28.4 percent of participants with severe depressive symptoms and 17.1 percent of those with frequent insomnia. Further analysis that adjusted for potential confounders found that the strongest independent risk factors for nightmares were ...
